Company: IMNN
Filing Date: 2025-04-04
Form Type: S-1
Source: 0001641172-25-002783
Chunk: 50

Company: Imunon, Inc.
Filing Date: 2025-04-04
Form: S-1
Chunk 50
---
30 |

<div align='center'>Up to 10,000,000 Shares of Common Stock

Up to 10,000,000 Common Warrants to Purchase 10,000,000 Shares of Common Stock

Up to 10,000,000 Pre-Funded Warrants to Purchase 10,000,000 Shares of Common Stock

Up to 10,000,000 Shares of Common Stock Underlying such Common Warrants and Pre-Funded Warrants

Up to 10,000,000 Shares of Common Stock Underlying Such Pre-Funded Warrants

Preliminary Prospectus

Lead Placement Agent

A.G.P.

Co-Placement Agent

Brookline Capital Markets

a division of Arcadia Securities, LLC

, 2025</div>

<div align='center'>PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 13. Other Expenses of Issuance and Distribution.

The following table sets forth the expenses to be incurred in connection with the offering described in this registration statement, all of which will be paid by the Company. All amounts are estimates except for the SEC registration fee and the Financial Industry Authority, Inc. (FINRA) filing fee:

| SEC                  
 registration fee     |     | $ |   3,062 |
| FINRA                
 filing fee           |     |   |   2,000 |
| Legal                
 fees and expenses    |     |   | 175,000 |
| Accounting           
 fees and expenses    |     |   |  25,000 |
| Printing             
 and related expenses |     |   |  10,000 |
| Miscellaneous        |     |   |  35,000 |
| Total                
 expenses             |     | $ | 250,062 |

Item 14. Indemnification of Directors and Officers.

The Company is incorporated under the laws of the State of Delaware. Our Bylaws provide that we shall, to the maximum extent and in the manner permitted by the DGCL, indemnify each of our directors and officers against expenses (including attorneys’ fees), judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceeding, arising by reason of the fact that such person is or was an agent of the Company; provided, however, that the Company may modify the extent of such indemnification by individual contracts with its directors and executive officers and, provided, further, that the Company shall not be required to indemnify any director or officer in connection with any proceeding (